ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,470Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 324

$1.16M Total Retail Price of All Prescriptions

Rank: 8 out of 324

576 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 576 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

31% of this provider’s 576 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 11,951 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 846 543 1 3
HYDROCODONE-ACETAMINOPHEN 790 354 S3 2 5
SIMVASTATIN 775 544 3 1
FUROSEMIDE 758 519 4 7
AMLODIPINE BESYLATE 698 422 5 4
LEVOTHYROXINE SODIUM 489 331 6 2
POTASSIUM CHLORIDE 476 287 7 8
METFORMIN HCL 469 242 8 9
WARFARIN SODIUM 446 371 9 10
OMEPRAZOLE 360 168 10 6
CARVEDILOL 343 258 11 22
OXYCODONE HCL-ACETAMINOPHEN 259 47 S2 12 105
ATORVASTATIN CALCIUM 259 130 12 12
METOPROLOL SUCCINATE 259 184 12 17
METOPROLOL TARTRATE 252 160 15 14
NEXIUM 246 79 16 33
GABAPENTIN 241 115 17 13
CLONIDINE HCL 228 107 18 53
PROAIR HFA 196 85 19 50
CRESTOR 194 108 20 28
KLOR-CON M20 191 152 21 52
TRAMADOL HCL 190 114 22 19
HYDROCHLOROTHIAZIDE 178 83 23 11
CYCLOBENZAPRINE HCL 176 42 R 24 51
TAMSULOSIN HCL 173 130 25 26
NOVOLOG 165 91 26 60
DONEPEZIL HCL 163 163 27 25
LANTUS 163 82 27 39
DIGOXIN 157 144 29 40
OXYCODONE-ACETAMINOPHEN 151 84 S2 30 97
ZOLPIDEM TARTRATE 141 61 31 20
TRIAMTERENE-HCTZ 139 89 32 46
OXYCODONE HCL 137 33 S2 33 71
FAMOTIDINE 134 77 34 62
NOVOLOG FLEXPEN 134 51 34 112
LOSARTAN POTASSIUM 131 86 36 15
PANTOPRAZOLE SODIUM 121 84 37 34
CITALOPRAM HBR 120 94 38 16
ATENOLOL 115 88 39 18
TRICOR 113 63 40 126
LANTUS SOLOSTAR 113 33 40 85
LIDODERM 111 37 42 110
ESCITALOPRAM OXALATE 110 65 43 54
CLONIDINE 110 101 43 218
CLOPIDOGREL 105 82 45 38
ADVAIR DISKUS 103 45 46 61
GLIMEPIRIDE 102 93 47 37
LANSOPRAZOLE 99 51 48 139
IBUPROFEN 97 52 49 130
DIOVAN 96 36 50 56
HYDRALAZINE HCL 93 72 51 113
INSULIN SYRINGE 92 65 52 102
CIPROFLOXACIN HCL 91 56 53 55
AZITHROMYCIN 89 54 54 48
CYMBALTA 87 11 55 45
VENLAFAXINE HCL ER 86 38 56 86
ALLOPURINOL 85 70 57 27
FENOFIBRATE 84 51 58 79
NAMENDA 82 80 59 31
ENDOCET 81 21 S2 60 161
SUCRALFATE 80 50 61 141
AMOX TR-POTASSIUM CLAVULANATE 80 36 61 153
PEN NEEDLE 80 18 61 146
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 53 64 35
FLUTICASONE PROPIONATE 78 53 65 32
FLUOXETINE HCL 76 20 66 67
QUETIAPINE FUMARATE 76 43 66 69
TRAZODONE HCL 75 29 68 42
GLIPIZIDE 74 53 69 73
GLYBURIDE 73 31 R 70 59
LYRICA 73 30 70 107
PREDNISONE 72 44 72 36
CARISOPRODOL 71 11 R 73 115
KLOR-CON M10 71 59 73 117
AMLODIPINE BESYLATE-BENAZEPRIL 71 39 73 100
VENTOLIN HFA 70 22 76 213
PLAVIX 70 51 76 63
DOXYCYCLINE HYCLATE 70 45 76 78
METFORMIN HCL ER 69 15 79 74
ISOSORBIDE MONONITRATE ER 69 51 79 65
CEPHALEXIN 68 49 81 90
MIRTAZAPINE 68 62 81 41
SPIRONOLACTONE 66 35 83 47
TRIAMCINOLONE ACETONIDE 66 47 83 154
COMBIVENT 65 27 85 212
ALENDRONATE SODIUM 63 61 86 24
MORPHINE SULFATE ER 62 35 S2 87 89
METOLAZONE 62 26 87 147
LOVASTATIN 62 42 87 43
DIVALPROEX SODIUM 62 51 87 99
PAROXETINE HCL 62 40 87 72
BACLOFEN 62 19 87 124
CLOTRIMAZOLE-BETAMETHASONE 61 28 93 182
MELOXICAM 60 28 94 29
PHENYTOIN SODIUM EXTENDED 59 0 95 128
1ST TIER UNIFINE PENTIPS 59 28 10 95 347
DILTIAZEM 24HR CD 58 47 97 81
LEVETIRACETAM 57 26 98 120
VESICARE 57 50 98 166
FENTANYL 57 14 S2 98 64
ENALAPRIL MALEATE 53 25 101 57
DICYCLOMINE HCL 52 19 102 214
LEVOFLOXACIN 52 28 102 84
SPIRIVA 52 28 102 70
EXELON 51 51 105 119
AMITRIPTYLINE HCL 51 25 R 105 66
POLYETHYLENE GLYCOL 3350 50 28 107 49
DIOVAN HCT 50 35 107 148
ZETIA 50 41 107 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.